The results present in this study suggested that TLR3 and TLR7 in immune organs both systemically modulated disease development in AIPI rats by reducing serum IgE release via IL-4 down-regulation, and which may provide a vital clue for further research in the asthma pathogenesis and suggest a new target for asthma treatment. This evidence concerns the gene IL4 and asthma.